[{"NetIncomeLossConverted_1_Q2_USD":-31493000.0,"NetIncomeLossConverted_2_Q2_USD":-92211000.0,"NetCashProvidedByUsedInOperatingActivitiesConverted_2_Q2_USD":-51162000.0,"CommonStockSharesOutstanding_0_Q2_shares":42168889.0,"StockholdersEquity_0_Q2_USD":710827000.0,"EarningsPerShareBasic_1_Q2_USD":-0.82,"EarningsPerShareBasic_2_Q2_USD":-2.47,"Assets_0_Q2_USD":725424000.0,"CommonStockSharesConverted_0_Q2_shares":42168889.0,"Ticker":"TPTX","CIK":"1595893","name":"TURNING POINT THERAPEUTICS, INC.","OfficialName":"Turning Point Therapeutics Inc. Common Stock","form":"10-Q","period":"20200630","fy":"2020.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1579986704.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20200810"}]